ID15895A - Formulasi untuk menurunkan kolesterol darah dan penyerapan lemak berbagai fungsi - Google Patents

Formulasi untuk menurunkan kolesterol darah dan penyerapan lemak berbagai fungsi

Info

Publication number
ID15895A
ID15895A IDP970367A ID970367A ID15895A ID 15895 A ID15895 A ID 15895A ID P970367 A IDP970367 A ID P970367A ID 970367 A ID970367 A ID 970367A ID 15895 A ID15895 A ID 15895A
Authority
ID
Indonesia
Prior art keywords
formulation
acid
fats
absorption
function
Prior art date
Application number
IDP970367A
Other languages
English (en)
Inventor
Ivan Dr Furda
Original Assignee
Ivan Dr Furda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivan Dr Furda filed Critical Ivan Dr Furda
Publication of ID15895A publication Critical patent/ID15895A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
IDP970367A 1996-02-14 1997-02-06 Formulasi untuk menurunkan kolesterol darah dan penyerapan lemak berbagai fungsi ID15895A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/601,388 US5736532A (en) 1996-02-14 1996-02-14 Multifunctional fat absorption and blood cholesterol reducing formulation comprising chitosan

Publications (1)

Publication Number Publication Date
ID15895A true ID15895A (id) 1997-08-14

Family

ID=24407295

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970367A ID15895A (id) 1996-02-14 1997-02-06 Formulasi untuk menurunkan kolesterol darah dan penyerapan lemak berbagai fungsi

Country Status (10)

Country Link
US (1) US5736532A (id)
EP (1) EP0881903B1 (id)
JP (1) JP2000504724A (id)
AT (1) ATE238805T1 (id)
AU (1) AU1852597A (id)
DE (1) DE69721497T2 (id)
ES (1) ES2199342T3 (id)
ID (1) ID15895A (id)
WO (1) WO1997029760A1 (id)
ZA (1) ZA971134B (id)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9912627A (pt) 1998-07-30 2002-02-13 Nutriceuticals Inc E Composição em suspensão lìquida estável, e, processos para preparação e uso da mesma e para tratamento de peso e de colesterol
GB9920393D0 (en) * 1999-08-27 1999-11-03 Medix Scient Uk Limited Plant extract mixtures and their uses
WO2003013471A2 (en) * 2001-08-08 2003-02-20 Paolina Galvao Pharmaceutical enteric coated composition comprising chitosan
US6897348B2 (en) 2001-12-19 2005-05-24 Kimberly Clark Worldwide, Inc Bandage, methods of producing and using same
US7419655B2 (en) * 2002-09-11 2008-09-02 Kimberly-Clark Worldwide, Inc. Skin care products
GB0302741D0 (en) * 2003-02-06 2003-03-12 Advanced Biopolymers As Use
RU2232775C1 (ru) * 2003-05-16 2004-07-20 Общество с ограниченной ответственностью "Инвест-Фарм" Способ получения ионосвязанных производных олигосахарида хитозана
US20070116713A1 (en) * 2005-11-22 2007-05-24 Gill Robert P Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
KR100882611B1 (ko) * 2006-11-14 2009-02-12 주식회사 키토라이프 표적 리간드로서 폴릭산이 도입된 유전자 전달체용저분자량 수용성 키토산 나노입자 및 이의 제조방법
US7659313B2 (en) * 2007-09-13 2010-02-09 Gateway Health Alliances, Inc. Methods and related compositions using specific indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals
CN102469782A (zh) 2010-06-18 2012-05-23 哈洛资源公司 包含壳聚糖的固态共混物的制剂及方法
SI2861229T1 (sl) * 2012-06-15 2021-03-31 Conaris Research Institute Ag Farmacevtski sestavek, ki vsebuje nikotinsko kislino in/ali nikotinamid in/ali triptofan, za pozitivno vplivanje na črevesno mikrobioto
ES2716115T3 (es) * 2013-12-13 2019-06-10 Conaris Res Institute Ag Una composición farmacéutica que contiene conbinaciones de nicotinamida y ácido 5-aminosalicílico para influir de forma beneficiosa en la microbiota intestinal y/o tratar la inflamación gastrointestinal
ES2788866T3 (es) 2013-12-13 2020-10-23 Conaris Res Institute Ag Una composición farmacéutica que contiene ácido nicotínico y/o nicotinamida para su uso en influir beneficiosamente en los niveles de lípidos en sangre mediante la modificación de la microbiota intestinal
ITUA20161937A1 (it) * 2016-03-23 2017-09-23 S I I T S R L Servizio Int Imballaggi Termosaldanti Preparazione per il controllo del peso corporeo a base di chitosano e cellulosa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223023A (en) * 1978-10-12 1980-09-16 Ivan Furda Nonabsorbable lipid binder
US5300494A (en) * 1986-06-06 1994-04-05 Union Carbide Chemicals & Plastics Technology Corporation Delivery systems for quaternary and related compounds
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
JP2667351B2 (ja) * 1992-03-24 1997-10-27 麒麟麦酒株式会社 食餌脂質消化吸収阻害剤および飲食品
US5420197A (en) * 1994-01-13 1995-05-30 Hydromer, Inc. Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives

Also Published As

Publication number Publication date
JP2000504724A (ja) 2000-04-18
ATE238805T1 (de) 2003-05-15
WO1997029760A1 (en) 1997-08-21
EP0881903A1 (en) 1998-12-09
US5736532A (en) 1998-04-07
ZA971134B (en) 1997-08-25
ES2199342T3 (es) 2004-02-16
DE69721497D1 (de) 2003-06-05
AU1852597A (en) 1997-09-02
EP0881903B1 (en) 2003-05-02
DE69721497T2 (de) 2004-03-18

Similar Documents

Publication Publication Date Title
ID15895A (id) Formulasi untuk menurunkan kolesterol darah dan penyerapan lemak berbagai fungsi
ATE236627T1 (de) Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
TR200200045T2 (tr) Temel yağ asitleri ve homosistein-düşürücü maddeler içeren farmasötik ve beslenme bileşimleri
KR19980700976A (id)
AU3435497A (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
DE60000133D1 (de) Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen
AU2740797A (en) Androstene derivatives
AU4185696A (en) Increasing creatine and glycogen concentration in muscle
PT1216041E (pt) Dieta com elevado teor de lipidos
ES2162586A1 (es) Composicion que comprende aceites ozonizados y/o otros productos naturales y/o sinteticos ozonizados, y su empleo en composiciones farmaceuticas, cosmeticas, dieteticas o de suplementos alimentarios, en los campos humano y veterinario
DE3669106D1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
WO2002064148A3 (en) Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders
TR199701294T1 (xx) Amoksisilin ve klavulanik asitten olu�an terkip.
GR3035613T3 (en) Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
SE9801647D0 (sv) Therapeutic composition
KR880010762A (ko) 소화성궤양의 치료방법 및 치료용 합성물(Composition and Method for Treatment of peptic Ulcers)
Patil et al. Effect of HCH on the lipid profiles of the fish Rasbora daniconius.
BE904737A (fr) Derives de l'acide octenoique.
LT2001072A (lt) Maisto papildas
MY129218A (en) Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid